Fig. 1From: Sequencing Mycobacteria and Algorithm-determined Resistant Tuberculosis Treatment (SMARTT): a study protocol for a phase IV pragmatic randomized controlled patient management strategy trialStrategy for whole genome sequencing-guided drug resistance profile determination and automated individualized treatment recommendationBack to article page